Nextera is delighted to announce the appointment of Thomas
Andersen as new CEO. He has significant business development
experience from the pharmaceutical and biotech industry. Thomas
Andersen has been working for Pronova BioPharma the last 5 years,
with responsibility for the US market. Prior to Pronova, Andersen spent
8 years at AstraZeneca in various roles.
